Albizia Amara

Albizia amara  (Roxb.) Boivin

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Mimosaceae.
Habitat Throughout southern India in dry forests, up to 900 m, and in some parts of Madhya Pradesh.
Ayurvedic Shirish (bark—grey or greenish).
Siddha / Tamil Thuringil.
Action Leaf and flower—antiinflammatory, used for boils and ulcers. Leaf—used for erysipelas. Seeds—astringent, antidiarrhoeal, antibacterial.
Taxonomic Cohort Genus Albizia (3 documented species); Family Mimosaceae (24 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Albizia amara (taxonomically cited with authority (Roxb.) Boivin) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Mimosaceae (primary family classification: Mimosaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Throughout southern India in dry forests, up to 900 m, and in some parts of Madhya Pradesh.

Across classical and vernacular Indian systems of medicine, Albizia amara is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Shirish (bark—grey or greenish); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Thuringil. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Albizia amara are: Leaf and flower—antiinflammatory, used for boils and ulcers. Leaf—used for erysipelas. Seeds—astringent, antidiarrhoeal, antibacterial. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Albizia amara establish the following evidence base: The seed extract showed DNA binding activity, which has been found to be due to pithecolibine alkaloids, budmunchiamines. Budmunchiamines are antibacterial, and they inhibit platelet aggregation and human lymphocyte transformation. They also show anti-inflammatory and cytotoxic activity. The leaves contain prodelphinidins, myricitrin, hyperin, quercitrin, transp-coumaric acid, cis-p-coumaric acid and trans-ferulic acid. The seeds contain echinocystic acid and taxifolin-3-O-beta-D xylopyranosyl-beta-D-arbinopyranoside. The oil from the seeds is said to cure leprosy and leucoderma.

image2

Botanical Reference 1: Albizia amara — Botanical specimen

image3

Botanical Reference 2: Albizia amara — Botanical specimen

image4

Botanical Reference 3: Albizia amara — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Albizia comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Albizia lebbeck (Action: Antiseptic, antibacterial, antiallergic, antidermatosis, antidysenteric….); Albizia procera (Action: Bark—a decoction is given in rheumatism and haemorrhage). Comparing Albizia amara alongside its congeners in genus Albizia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Mimosaceae encompasses 24 documented medicinal species (1.32% of the 1,814-species flora). Other representative medicinal members of Mimosaceae include: Acacia arabica indica (Babbuula), Acacia canescens (Aadaari), Acacia catechu (Khadira), Acacia chundra (Khadira), Dichrostachys cinerea (Virataru). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 24 medicinal species of family Mimosaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Albizia amara follow the plant-part modalities specified under its therapeutic action (Leaf and flower—antiinflammatory, used for boils and ulcers. Leaf—used for erysipelas. Seeds—astringent, antidiarrhoeal, antibacterial), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Albizia amara integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top